130 related articles for article (PubMed ID: 8579066)
1. High-dose biscoclaurine alkaloids together with prednisolone raise platelet counts in chronic idiopathic thrombocytopenic purpura.
Saito N; Takemori N; Hirai K; Onodera R; Watanabe S; Kohgo Y
Am J Hematol; 1996 Feb; 51(2):173-4. PubMed ID: 8579066
[No Abstract] [Full Text] [Related]
2. Pharmacological characterization of cepharanthin in chronic idiopathic thrombocytopenic purpura.
Sato T; Morita I; Fujita H; Ono M; Kimishima A; Tomiyama J; Murota S
Platelets; 2001 May; 12(3):156-62. PubMed ID: 11304417
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of cepharanthin for chronic idiopathic thrombocytopenic purpura].
Nakayama S; Matsushita A; Ichiba S; Nagai K
Rinsho Ketsueki; 1992 Mar; 33(3):408-9. PubMed ID: 1578649
[TBL] [Abstract][Full Text] [Related]
4. [Chronic idiopathic thrombocytopenic purpura].
Treppendahl MB; Nielsen OJ
Ugeskr Laeger; 2004 Sep; 166(39):3389-93. PubMed ID: 15515391
[No Abstract] [Full Text] [Related]
5. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur.
Ou CY; Hsieh KS; Chiou YH; Chang YH; Ger LP
Acta Paediatr Taiwan; 2006; 47(5):226-31. PubMed ID: 17352309
[TBL] [Abstract][Full Text] [Related]
6. Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan.
Inaba T; Mizuno M; Take S; Suwaki K; Honda T; Kawai K; Fujita M; Tamura T; Yokota K; Oguma K; Okada H; Shiratori Y
Eur J Clin Invest; 2005 Mar; 35(3):214-9. PubMed ID: 15733077
[TBL] [Abstract][Full Text] [Related]
7. Genetic analysis of HLA- and HPA-typing in idiopathic (autoimmune) thrombocytopenic purpura patients treated with cepharanthin.
Nomura S; Matsuzaki T; Yamaoka M; Ozaki Y; Nagahama M; Yoshimura C; Kagawa H; Nakayama S; Fukuhara S
Autoimmunity; 1999; 30(2):99-105. PubMed ID: 10435723
[TBL] [Abstract][Full Text] [Related]
8. Durable response to a single dose of Anti D in immune thrombocytopenic purpura in an adult with underlying human immunodeficiency viral infection.
Hewamana S; Pepper C; Karunanithi K; Jenkins C; Rowntree C
Ann Hematol; 2009 Nov; 88(11):1155-6. PubMed ID: 19399500
[No Abstract] [Full Text] [Related]
9. [High-dose cepharanthin therapy of idiopathic thrombocytopenic purpura].
Kobayashi M; Katayama T; Ochiai S; Yoshida M; Kaito K; Masuoka H; Shimada T; Nishiwaki K; Sakai O
Rinsho Ketsueki; 1992 Mar; 33(3):405-7. PubMed ID: 1578648
[TBL] [Abstract][Full Text] [Related]
10. Low dose cepharanthine ameliorates immune thrombocytopenic purpura associated with multiple myeloma.
Tabata R; Tabata C; Tazoh A; Nagai T
Int Immunopharmacol; 2012 Jul; 13(3):242-4. PubMed ID: 22561120
[TBL] [Abstract][Full Text] [Related]
11. [Helicobacter pylori eradication based upon a drug sensitivity test effectively increased platelet count in a patient with refractory idiopathic thrombocytopenic purpura].
Asaumi N; Masuda K; Yoshida C; Kiguchi T; Niiya M; Niiya K; Tanimoto M
Rinsho Ketsueki; 2003 Jul; 44(7):480-2. PubMed ID: 12931570
[TBL] [Abstract][Full Text] [Related]
12. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
13. [Clinical efficacy of high-dose cepharanthine for idiopathic thrombocytopenic purpura: retrospective multicenter analysis].
Takahata M; Hashino S; Fujimoto K; Endo T; Kobayashi N; Kurosawa M; Iwasaki H; Miyake T; Kohda K; Maekawa I; Sasagawa H; Tsustumi Y; Miyagishima T; Tanaka J; Imamura M; Teshima T
Rinsho Ketsueki; 2012 Dec; 53(12):1983-90. PubMed ID: 23318963
[TBL] [Abstract][Full Text] [Related]
14. Experience with high dose dexamethasone in the treatment of chronic symptomatic immune thrombocytopaenia.
Van Riet FA; Wessels G; Hesseling PB
East Afr Med J; 1999 Oct; 76(10):571-4. PubMed ID: 10734508
[TBL] [Abstract][Full Text] [Related]
15. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
[TBL] [Abstract][Full Text] [Related]
16. Effect of eradication of Helicobacter pylori on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura: a controlled trial.
Rostami N; Keshtkar-Jahromi M; Rahnavardi M; Keshtkar-Jahromi M; Esfahani FS
Am J Hematol; 2008 May; 83(5):376-81. PubMed ID: 18183613
[TBL] [Abstract][Full Text] [Related]
17. Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura-a randomized controlled trial.
Suzuki T; Matsushima M; Masui A; Watanabe K; Takagi A; Ogawa Y; Shirai T; Mine T
Am J Gastroenterol; 2005 Jun; 100(6):1265-70. PubMed ID: 15929755
[TBL] [Abstract][Full Text] [Related]
18. Treatment of childhood acute immune thrombocytopenic purpura with high-dose methylprednisolone, intravenous immunoglobulin, or the combination of both.
Gereige RS; Barrios NJ
P R Health Sci J; 2000 Mar; 19(1):15-8. PubMed ID: 10761200
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting development of chronic disease in Nordic children with acute onset of idiopathic thrombocytopenic purpura.
Rosthøj S; Hedlund-Treutiger I; Rajantie J; Zeller B;
Br J Haematol; 2005 Jul; 130(1):148-9; author reply 150. PubMed ID: 15982360
[No Abstract] [Full Text] [Related]
20. Absence of platelet recovery following Helicobacter pylori eradication in childhood chronic idiopathic thrombocytopenic purpura: a multi-center randomized controlled trial.
Treepongkaruna S; Sirachainan N; Kanjanapongkul S; Winaichatsak A; Sirithorn S; Sumritsopak R; Chuansumrit A
Pediatr Blood Cancer; 2009 Jul; 53(1):72-7. PubMed ID: 19301380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
